FDA Drug Application (022221) for AKTEN by AKORN

Back to FDA Applications sponsored by AKORN

Application Number022221
Product Number001
FormGEL;OPHTHALMIC
Dosage3.5%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAKTEN
Active IngredientLIDOCAINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient LIDOCAINE HYDROCHLORIDE48


Back to FDA Applications sponsored by AKORN